Endothelium-specific deletion of amyloid-β precursor protein exacerbates endothelial dysfunction induced by aging

Aging (Albany NY). 2021 Aug 12;13(15):19165-19185. doi: 10.18632/aging.203401. Epub 2021 Aug 12.

Abstract

The physiological function of amyloid precursor protein (APP) in the control of endothelial function during aging is unclear. Aortas of young (4-6 months old) and aged (23-26 months old) wild-type (WT) and endothelium-specific APP-deficient (eAPP-/-) mice were used to study aging-induced changes in vascular phenotype. Unexpectedly, aging significantly increased protein expression of APP in aortas of WT mice but not in aortas of eAPP-/- mice thereby demonstrating selective upregulation APP expression in vascular endothelium of aged aortas. Most notably, endothelial dysfunction (impairment of endothelium-dependent relaxations) induced by aging was significantly exacerbated in aged eAPP-/- mice aortas as compared to age-matched WT mice. Consistent with this observations, endothelial nitric oxide synthase (eNOS) protein expression was significantly decreased in aged eAPP-/- mice as compared to age matched WT mice. In addition, protein expression of cyclooxygenase 2 and release of prostaglandins were significantly increased in both aged WT and eAPP-/- mice. Notably, treatment with cyclooxygenase inhibitor, indomethacin, normalized endothelium-dependent relaxations in aged WT mice, but not in aged eAPP-/- mice. In aggregate, our findings support the concept that aging-induced upregulation of APP in vascular endothelium is an adaptive response designed to protect and preserve expression and function of eNOS.

Keywords: aging; amyloid precursor protein; endothelial nitric oxide synthase; endothelium; prostaglandins.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aging / physiology*
  • Amyloid beta-Protein Precursor / genetics*
  • Animals
  • Aorta, Thoracic / drug effects
  • Aorta, Thoracic / metabolism
  • Cyclooxygenase 2 / metabolism
  • Cyclooxygenase Inhibitors / pharmacology
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / metabolism*
  • Indomethacin / pharmacology
  • Male
  • Mice
  • Mice, Knockout
  • Nitric Oxide Synthase Type III / metabolism
  • Prostaglandins / metabolism
  • Vasoconstriction / drug effects*
  • Vasodilation / drug effects*

Substances

  • APP protein, mouse
  • Amyloid beta-Protein Precursor
  • Cyclooxygenase Inhibitors
  • Prostaglandins
  • Nitric Oxide Synthase Type III
  • Cyclooxygenase 2
  • Indomethacin